Clinical Trial Update: Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating the combination of eltrombopag with azacitidine in myelodysplastic syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Thrombocytopenia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: Nordic MDS Group | Conditions: Myelodysplastic Syndrome, Thrombocytopenia | Phase 1 | Status: COMPLETED